Extended Benefit with Bronchitol in Second Phase III Cystic Fibrosis Trial
16.12.2010 - Extended Benefit with Bronchitol in Second Phase III Cystic Fibrosis Trial
Pharmaxis today announced positive first results for the open label component of its second international Phase III trial of Bronchitol in people with cystic fibrosis.